Jingfang Ju

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Andrew T. Fesler · 4 shared papers, 2018–2024 · strength 0.67
   • Paper Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma. DOI 10.1016/j.omton.2024.200769↗
   • Paper Development of microRNA-based therapy for pancreatic cancer. DOI 10.1097/jp9.0000000000000029↗
   • Paper microRNA based prognostic biomarkers in pancreatic Cancer. DOI 10.1186/s40364-018-0131-1↗
2. A.S. Pal · 2 shared papers, 2023–2024 · strength 0.55
   • Paper Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. DOI 10.3390/ijms242417523↗
   • Paper Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma. DOI 10.1016/j.omton.2024.200769↗
3. Huaizhi Wang · 4 shared papers, 2014–2020 · strength 0.35
   • Paper microRNA based prognostic biomarkers in pancreatic Cancer. DOI 10.1186/s40364-018-0131-1↗
   • Paper Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.omtn.2019.11.010↗
   • Paper Transcriptomic changes associated with DKK4 overexpression in pancreatic cancer cells detected by RNA-Seq. DOI 10.1007/s13277-015-4379-x↗
4. Shixiang Guo · 4 shared papers, 2014–2020 · strength 0.32
   • Paper microRNA based prognostic biomarkers in pancreatic Cancer. DOI 10.1186/s40364-018-0131-1↗
   • Paper Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.omtn.2019.11.010↗
   • Paper Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB sign… DOI 10.1038/onc.2016.90↗
5. John G. Yuen · 1 shared paper, 2024 · strength 0.24
   • Paper Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma. DOI 10.1016/j.omton.2024.200769↗
6. Yongsheng Ouyang · 3 shared papers, 2014–2016 · strength 0.17
   • Paper Transcriptomic changes associated with DKK4 overexpression in pancreatic cancer cells detected by RNA-Seq. DOI 10.1007/s13277-015-4379-x↗
   • Paper Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB sign… DOI 10.1038/onc.2016.90↗
   • Paper miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by dow… DOI 10.1016/j.canlet.2013.10.009↗
7. Xianxing Wang · 1 shared paper, 2020 · strength 0.11
   • Paper Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.omtn.2019.11.010↗
8. Wenjie Huang · 1 shared paper, 2020 · strength 0.11
   • Paper Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.omtn.2019.11.010↗
9. H Wang · 1 shared paper, 2016 · strength 0.05
   • Paper Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB sign… DOI 10.1038/onc.2016.90↗
10. J Li · 1 shared paper, 2016 · strength 0.05
    • Paper Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB sign… DOI 10.1038/onc.2016.90↗
11. Bing Ni · 1 shared paper, 2016 · strength 0.05
    • Paper Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB sign… DOI 10.1038/onc.2016.90↗
12. Zhiping Zhao · 1 shared paper, 2016 · strength 0.05
    • Paper Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB sign… DOI 10.1038/onc.2016.90↗
13. Heshui Wu · 1 shared paper, 2016 · strength 0.05
    • Paper Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB sign… DOI 10.1038/onc.2016.90↗
14. Yichen Tang · 1 shared paper, 2014 · strength 0.04
    • Paper miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by dow… DOI 10.1016/j.canlet.2013.10.009↗
15. Ping Bie · 1 shared paper, 2014 · strength 0.04
    • Paper miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by dow… DOI 10.1016/j.canlet.2013.10.009↗
16. Xuejun Xu · 1 shared paper, 2014 · strength 0.04
    • Paper miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by dow… DOI 10.1016/j.canlet.2013.10.009↗
17. Jian Li · 1 shared paper, 2014 · strength 0.04
    • Paper miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by dow… DOI 10.1016/j.canlet.2013.10.009↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.